RXRX's logo.
Ticker Symbol: RXRX

Recursion Pharmaceuticals Inc - Class A

$20.00 - 02-12-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0001601830

Company Profile

Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Central to its mission is the Recursion Operating System, or Recursion OS, that combines an advanced infrastructure layer to generate what Recursion believes is one of the world's largest and fastest-growing proprietary biological and chemical datasets and the Recursion Map, a suite of custom software, algorithms, and machine learning tools that the company uses to explore foundational biology unconstrained by human bias and navigate to new biological insights which may accelerate its programs. biotechnology company scaling more like a technology company.

Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Standard Industrial Classification Code (SIC code): 2836
Address: N/A
CEO: N/A
Tags: N/A

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $7.39
Change: $0.23 ( 3.21%)
Days Range: $7.00 - $7.51
Beta: 1.77
52wk. High: $16.75
52wk. Low: $4.54
Ytd. Change -3.92%
50 Day Moving Average: $7.65
200 Day Moving Average: $8.33
Shares Outstanding: 204038332

Valuation

Market Cap: 150.8B
PE Ratio: -5.36
EPS (TTM): -1.38

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A